In the News
The Covid-19 pandemic boosted demand for quick diagnostic testing to unprecedented levels, bringing into focus the crucial role of pathology players in the healthcare ecosystem. What trends in healthcare and medicine are driving the regional growth potential of the pathology industry? We find out from Dr Christopher Ting, CEO of Pathology Group Asia, which runs a network of pathology labs across Southeast Asia, including Innoquest Pathology in Malaysia (formerly known as Gribbles Pathology).
Electronic prescription (e-prescription) telemedicine provider DOC2US has inked a strategic collaboration with AIA Malaysia to provide virtual health services and wellness programmes to the insurer’s individual and corporate customers.
Dr Sim: Health Ministry approves RM21 million to upgrade lab facilities in Sarawak hospitals to increase Covid-19 testing capacity - Borneo Post Online
KUCHING (Jan 23): The Health Ministry has approved an allocation of RM21 million to upgrade the facilities, equipment and reagents of the various labs in government hospitals in Sarawak for polymerase chain reaction (PCR) testing in a bid to increase Covid-19 testing capacity in the state. In revealing this, Local Government and Housing Minister Dato Sri Dr Sim Kui Hian said
Gribbles Pathology, Quantum Diagnostics and Clinipath laboratories in Consortium aim to conduct over 5,000 tests daily with a 24-hour turnaround time